Europe — EMA

Palonosetron Beta

Palonosetron, the active ingredient in Palonosetron Beta, is a 5‑HT3 receptor antagonist presented as a unknown/unknown for injection use.

Palonosetron

Request sourcing

Pack/s

What is Palonosetron?

Palonosetron, the active ingredient in Palonosetron Beta, is a 5‑HT3 receptor antagonist presented as a unknown/unknown for injection use. It treats and prevents chemotherapy‑induced nausea and vomiting in adult oncology patients. GNH USA supplies Palonosetron Beta as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

GNH USA supplies Palonosetron Beta as a licensed ...

What is Palonosetron used for?

Palonosetron Beta ...

What are the side effects of Palonosetron?

Common ...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →